Tyrvaya for Dry Eye Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective of this study is to evaluate whether twice-daily use of Tyrvaya improves contact lens comfort in contact lens wearers.
Are You a Good Fit for This Trial?
This trial is for adults (18+) who wear daily disposable soft contact lenses at least 5 days a week, have dry eye symptoms and discomfort with their contacts, good vision with correction (20/40 or better), and are willing to use only the study nasal spray for dry eyes during the 3-month study.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Tyrvaya
Trial Overview
The study tests whether using Tyrvaya (varenicline solution) nasal spray twice daily can improve comfort in people who experience dryness while wearing contact lenses. Participants will continue their usual lens routine but must not use other prescription dry eye treatments.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be given Tryvaya (Varenicline Solution Nasal Spray 0.03 mg) and instructed to use it twice daily while wearing their contact lenses to determine if the spray relieves symptoms associated with dry eye disease, and thus increases contact lens comfort.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ocular Aesthetics, LLC dba Ocular Clinical Trials
Lead Sponsor
Viatris Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.